23 November 2020, USD/JPY
USDJPY trading plan:
Pfizer Inc applied to U.S. health regulators for emergency use authorization of its COVID-19 vaccine. The FDA said on Friday it would hold a meeting of the advisory committee on Dec. 10 at which members would discuss the vaccine. The agency declined to predict how long its review would take, although both Pfizer and U.S. Health Secretary Alex Azar have said the FDA could authorize the vaccine in mid-December. The possibility of a vaccine soon raised hopes for the end of a pandemic that has claimed more than a quarter of a million lives in the United States and over 1.3 million worldwide. This is a good signal for the stock market and USDJPY, which has a correlation with the shares.
Investment idea: Buy 103.40 and take profit 103.80